ASX pares gains after Trump’s tariffs threat sends nerves through the market. Meanwhile, Bitcoin slips as it awaits a bit more clarity from the new POTUS.
Recce Pharmaceuticals has wrapped up dosing of all patients in its phase II clinical trial of its topical gel treatment for acute bacterial skin and skin structure infections.
The team behind the success of Latin Resources and now helming Core Energy Minerals – formerly Oar Resources – has now set its sights on uranium in Australia.
